Foghorn Therapeutics (FHTX) Change in Acquisitions & Divestments (2021 - 2026)

Foghorn Therapeutics' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $49.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 38.9% year-over-year to $49.2 million; the TTM figure through Mar 2026 stood at $212.0 million (down 16.72% YoY), while the FY2025 annual figure was $243.3 million, up 4.67% from the prior year.
• Change in Acquisitions & Divestments was $49.2 million for Q1 2026 at Foghorn Therapeutics, up from $47.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $80.6 million in Q1 2025 to a low of $19.0 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $53.6 million across 5 years, with a median of $53.1 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 79.89% in 2022, then surged 303.02% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $38.1 million in 2022, then rose by 16.17% to $44.3 million in 2023, then jumped by 41.02% to $62.4 million in 2024, then fell by 24.36% to $47.2 million in 2025, then grew by 4.25% to $49.2 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $49.2 million (Q1 2026), $47.2 million (Q4 2025), and $39.6 million (Q3 2025), per Business Quant data.